A Phase III Study of Intensive Cytarabine (Ara-C) Induction Followed by Cyclosporine (CSA) Modulation of Drug Resistance in De Novo Pediatric AML: POG 9421
Becton DL, Ravindranath Y, Dahl GV, Berkow RL, Chang M, Stine KC, Et al. A Phase III Study of Intensive Cytarabine (Ara-C) Induction Followed by Cyclosporine (CSA) Modulation of Drug Resistance in De Novo Pediatric AML: POG 9421. 43rd Annual American Society of Hematology. 2001; 98 (11):1929.